Clinical trials in rheumatoid arthritis: a status report from the ClinicalTrials.gov website
- 19 July 2011
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 32 (6) , 1831-1835
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trialAnnals of the Rheumatic Diseases, 2011
- Registering Clinical Trial Results2010
- Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trialThe Lancet, 2008
- The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentArthritis & Rheumatism, 2005
- Clinical Trial RegistrationJAMA, 2004
- Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trialArthritis & Rheumatism, 2003
- Current methods of the U.S. Preventive Services Task ForceAmerican Journal of Preventive Medicine, 2001
- Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trialThe Lancet, 1999
- Trials: the next 50 yearsBMJ, 1998
- The assessment and prediction of functional disability in rheumatoid arthritis.1991